# Drug Etiology of Aplastic Anemia and Related Dyscrasias

> **NCT00005302** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Blood Disease
- Anemia, Aplastic
- Agranulocytosis
- Purpura, Thrombocytopenic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00005302
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1985-04
- **Primary completion:** —
- **Final completion:** 1992-06
- **Target enrollment:** — (—)
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005302, "Drug Etiology of Aplastic Anemia and Related Dyscrasias". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00005302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*